Life sciences industry’s search for talent is becoming more challenging: study

By Greg Slabodkin, ScienceBoard Editor in Chief
June 15, 2022

While more professionals are engaged in life sciences research in the U.S. and a record number of people are graduating in the biological and biomedical sciences, the ability of employers to find life sciences research talent is proving extremely difficult, according to a new report from CBRE.

“Fierce competition for talent -- exacerbated by demographic changes, pandemic-induced burnout, and shifting family responsibilities -- presents challenges as the industry seeks to meet growing demand for its products and services,” states the report.

CBRE’s report, “Life Sciences Research Talent 2022: The Search to Sustain an Industry Boom,” finds that the U.S. life sciences industry is among the “hardest-hit” industries with scientific and professional roles under the most intense pressure.

As the report notes, the innovation of the life sciences industry is driven by biochemists, biological scientists, chemists, and skilled laboratory support staff. The largest research occupation is medical scientists (excluding epidemiologists), according to CBRE, a role that has grown 131% over the past 20 years.

Chemists are the next largest life sciences research occupation. However, the role has grown below average over the past 20 years as the industry has shifted to biologics over recent decades. During that time, much greater growth has been among biochemists and biophysicists (167%), other biological scientists (87%), and most notably data scientists (1,363%).

Still, as total employment has rebounded from the 2020 downturn, the report points out that the life sciences industry “has continued to grow at its fastest pace on record” but with most of the new jobs in roles outside of the core research functions.

“The life sciences revolution remains firmly in place but the search for talent has become more challenging,” the report concludes. The report comes as biotech companies met this week at the 2022 Biotechnology Innovation Organization (BIO) International Convention in San Diego.

Patient advocacy organizations look to partner with pharma companies
Patient advocacy organizations are looking to partner with pharmaceutical companies, offering resources and expertise to maximize the impact and efficiency...
How to develop a sustainable portfolio for cell, gene therapy platforms
Michael Retterath, a Biotechnology Innovation Organization International Convention 2022 panelist and chief business officer at Spark Therapeutics, spoke...
Biotech industry execs, not scientists, remain male-dominated
A panel at the 2022 Biotechnology Innovation Organization International Convention will explore how to close the gender gap in the biotech industry and...
LabCentral Ignite receives $400K grant to improve diversity in STEM
LabCentral Ignite has been awarded $400,000 in grants and matching awards from the U.S. Economic Development Administration and Breakthrough Properties,...
How diversity, inclusion help one company turn sci-fi into sci-fact
Juliana Blum, PhD, co-founder and executive vice president of corporate development at Humacyte, spoke with ScienceBoard about diversity and...
Experience sharing is critical for women in science
Sharing experiences with future generations is key to moving science and biotechnology forward. As a female leader of a biotechnology company, Dr. Bridget...
Giving a voice to professionals of color is important in the life sciences
Creating an environment where professionals of color feel empowered to use their voice and confidence that they will be heard is critical to business...

Copyright © 2022

Last Updated 6/15/2022 2:32:08 PM